Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-045954
Filing Date
2024-11-14
Accepted
2024-11-14 16:34:36
Documents
79
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1503751
2 ex31-1.htm EX-31.1 19012
3 ex31-2.htm EX-31.2 18583
4 ex32-1.htm EX-32.1 10179
  Complete submission text file 0001493152-24-045954.txt   7544422

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE biaf-20240930.xsd EX-101.SCH 47833
6 XBRL CALCULATION FILE biaf-20240930_cal.xml EX-101.CAL 72160
7 XBRL DEFINITION FILE biaf-20240930_def.xml EX-101.DEF 231329
8 XBRL LABEL FILE biaf-20240930_lab.xml EX-101.LAB 458026
9 XBRL PRESENTATION FILE biaf-20240930_pre.xml EX-101.PRE 364203
81 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 1332668
Mailing Address 22211 WEST INTERSTATE-10 SUITE 1206 SAN ANTONIO TX 78257
Business Address 22211 WEST INTERSTATE-10 SUITE 1206 SAN ANTONIO TX 78257 210-698-5334
bioAffinity Technologies, Inc. (Filer) CIK: 0001712762 (see all company filings)

EIN.: 465211056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41463 | Film No.: 241463346
SIC: 8731 Services-Commercial Physical & Biological Research
(CF Office: 08 Industrial Applications and Services)